GPX Medical inleder process för att noteras under hösten 2020

GPX Medical inleder process för att noteras under hösten 2020

Styrelsen i GPX Medical har beslutat i nära dialog med huvudägarna, att inleda processen för att notera bolaget på Nasdaq First North Growth Market Stockholm med mål om en notering under hösten 2020. Bolaget har under det senaste året nått betydande milstolpar för...

About GPX Medical

GPX Medical AB was formed in 2016 as a subsidiary to Gasporox AB (publ) with the aim to develop and commercialize medical applications of the GASMAS technology. The company is owned by Gasporox AB (publ) to 53,3%, by Norsk Elektro Optikk AS to 36,2% and by the team to 10,5%. The company is located in Lund, Sweden. Org. nbr. 559069-9012.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hs@gpxmedical.se

Contact

GPX Medical AB
Tellusgatan 13
224 57 Lund
Sweden
info@gpxmedical.se